Akso Health Group
AHG · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $14,778 | $2,414 | $13,182 | $6,000 |
| % Growth | 512.1% | -81.7% | 119.7% | – |
| Cost of Goods Sold | $15,059 | $2,292 | $11,913 | $5,395 |
| Gross Profit | -$282 | $122 | $1,269 | $605 |
| % Margin | -1.9% | 5.1% | 9.6% | 10.1% |
| R&D Expenses | $0 | $0 | $0 | $421 |
| G&A Expenses | $3,641 | $8,592 | $15,529 | $2,670 |
| SG&A Expenses | $3,641 | $8,760 | $15,536 | $3,061 |
| Sales & Mktg Exp. | $0 | $168 | $7 | $392 |
| Other Operating Expenses | $162,381 | $0 | $0 | $383 |
| Operating Expenses | $166,023 | $8,760 | $15,536 | $3,866 |
| Operating Income | -$166,304 | -$8,638 | -$14,267 | -$3,260 |
| % Margin | -1,125.4% | -357.8% | -108.2% | -54.3% |
| Other Income/Exp. Net | $34 | -$454 | $1,200 | -$748 |
| Pre-Tax Income | -$166,270 | -$9,092 | -$13,066 | -$4,008 |
| Tax Expense | -$30,801 | $25 | $18 | $93 |
| Net Income | -$134,977 | -$9,459 | -$1,360 | -$16,850 |
| % Margin | -913.4% | -391.8% | -10.3% | -280.8% |
| EPS | -0.48 | -0.45 | -0.06 | -2.55 |
| % Growth | -6.7% | -650% | 97.6% | – |
| EPS Diluted | -0.48 | -0.39 | -0.06 | -2.55 |
| Weighted Avg Shares Out | 285,096 | 20,814 | 7,622 | 6,624 |
| Weighted Avg Shares Out Dil | 285,096 | 23,826 | 7,622 | 6,624 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $804 |
| Depreciation & Amortization | $2,150 | $0 | $0 | $18 |
| EBITDA | -$1,773 | -$8,638 | -$14,267 | -$3,186 |
| % Margin | -12% | -357.8% | -108.2% | -53.1% |